Tunlametinib
Product Specifications
CAS Number
1801756-06-8
Synonyms
HL-085
SKU
C01969-5mg
Target
MEK
Applications
Protein Tyrosine Kinase
Additionnal Information
Tunlametinib (HL-085) is a highly selective and oral inhibitor of MEK1/2 with an IC50 of 1.9 nM for MEK1, with the potential to treat RAS/RAF mutant cancers. It also induces cell cycle arrest at the G0/G1 phase and promotes apoptosis in a dose-dependent manner. It also exhibits antitumor activity in patients with advanced NRAS-mutant melanoma.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15163686 1 Vial
Lentiviral human PAIP1 shRNA (UAS) - Lentiviral human PAIP1 shRNA (UAS) (100)
Ask
View Details